Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system
ANNALS OF THE RHEUMATIC DISEASES (2014)
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 73, Issue 6, Pages 954-957Publisher
BMJ PUBLISHING GROUP
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022
Bas Dijkshoorn, Reinder Raadsen, Michael T. Nurmohamed
JOURNAL OF CLINICAL MEDICINE (2022)
Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis
Anthony James Ocon, George Reed, Dimitrios A. Pappas, Jeffrey R. Curtis, Joel M. Kremer
ANNALS OF THE RHEUMATIC DISEASES (2021)
Risk factors for hypertension in rheumatoid arthritis patients-A systematic review
Brook Hadwen, Saverio Stranges, Lillian Barra
AUTOIMMUNITY REVIEWS (2021)
Higher Risk of Cardiovascular Diseases in Rheumatoid Arthritis Patients Without Methotrexate Treatment
Karel Hloch, Martin Dosedel, Jurjen Duintjer Tebbens, Lenka Zaloudkova, Helena Medkova, Jiri Vlcek, Tomas Soukup, Petr Pavek
FRONTIERS IN PHARMACOLOGY (2021)
How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway
Benedicte Delcoigne, Sella A. Provan, Eirik K. Kristianslund, Johan Askling, Lotta Ljung
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)
Myeloperoxidase as an important predictor of cardiovascular risk in individuals with rheumatoid arthritis
Elisangela Gueiber Montes, Fabiana Postiglioni Mansani, Alceu de Oliveira Toledo Junior, Marcelo Derbli Schafranski, Bruno Queiroz Zardo, Fabio Andre dos Santos, Sabrina Grassiolli, Lorena de Freitas Calixto, Romulo Lopes da Costa, Felicio de Freitas Netto, Jose Carlos Rebuglio Vellosa
INFLAMMOPHARMACOLOGY (2021)
Periodontal Disease Augments Cardiovascular Disease Risk Biomarkers in Rheumatoid Arthritis
Jeneen Panezai, Ambereen Ghaffar, Mohammad Altamash, Mikael Aberg, Thomas E. Van Dyke, Anders Larsson, Per-Erik Engstrom
BIOMEDICINES (2022)
PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
Aikaterini Arida, Aigli-Ioanna Legaki, Evrydiki Kravvariti, Athanasios Protogerou, Petros P. Sfikakis, Antonios Chatzigeorgiou
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis
Tate M. Johnson, Harlan R. Sayles, Joshua F. Baker, Michael D. George, Punyasha Roul, Cheng Zheng, Brian Sauer, Katherine P. Liao, Daniel R. Anderson, Ted R. Mikuls, Bryant R. England
ANNALS OF THE RHEUMATIC DISEASES (2021)
Therapy with JAK inhibitors or bDMARDs and the risk of cardiovascular events in the Dutch rheumatoid arthritis population
Calin D. Popa, Merel A. A. Opdam, Nathan den Broeder, Hanne van Ballegooijen, Kelly Mulder, Kayleigh M. van de Wiel, Noortje van Herwaarden, Maike H. M. Wientjes, Alfons A. den Broeder
RHEUMATOLOGY (2023)
Cardiovascular Risk Factors before Onset of Rheumatoid Arthritis Are Associated with Cardiovascular Events after Disease Onset: A Case-Control Study
Heidi Kokkonen, Linda Johansson, Hans Stenlund, Solbritt Rantapaa-Dahlqvist
JOURNAL OF CLINICAL MEDICINE (2022)
Relevance of circulating markers of endothelial activation for cardiovascular risk assessment in rheumatoid arthritis: a narrative review
Celian Peyronnel, Perle Totoson, Helene Martin, Celine Demougeot
LIFE SCIENCES (2023)
SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis
Ivan Ferraz-Amaro, Alfonso Corrales, Belen Atienza-Mateo, Nuria Vegas-Revenga, Diana Prieto-Pena, Julio Sanchez-Martin, Cristina Almeida, Juan Carlos Quevedo-Abeledo, Ricardo Blanco, Miguel A. Gonzalez-Gay
DIAGNOSTICS (2021)
Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?
Gulsen Ozen, Sofia Pedro, Rebecca Schumacher, Teresa Simon, Kaleb Michaud
RMD OPEN (2021)
Rheumatoid Arthritis and Cardiovascular Risk: Retrospective Matched-Cohort Analysis Based on the RECORD Study of the Italian Society for Rheumatology
Lisa Argnani, Anna Zanetti, Greta Carrara, Ettore Silvagni, Giulio Guerrini, Antonella Zambon, Carlo Alberto Scire
FRONTIERS IN MEDICINE (2021)
Correspondence on Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry by Sparks et al
Ronald F. van Vollenhoven, Sander W. Tas, Michael T. Nurmohamed
ANNALS OF THE RHEUMATIC DISEASES (2023)
Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial
T. Rusman, M. A. C. van der Weijden, M. T. Nurmohamed, C. J. van Denderen, R. B. M. Landewe, P. M. Bet, C. M. A. van der Bijl, C. J. Van der Laken, I. E. van der Horst-Bruinsma
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)
Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial
J. Ruwaard, M. J. L' Ami, E. L. Kneepkens, C. L. M. Krieckaert, M. T. Nurmohamed, F. Hooijberg, A. W. R. van Kuijk, J. C. van Denderen, L. Burgemeister, T. Rispens, M. Boers, G. J. Wolbink
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)
Patients' and health-care professionals' perspectives on adverse drug reaction burden attributed to the use of biological DMARDs: a qualitative study
Henrike J. Westerink, Leanne J. Kosse, Naomi T. Jessurun, Astrid Tubergen, Harald E. Vonkeman, Mike T. Nurmohamed, Bart J. F. van den Bemt, Marieke de Vries
EXPERT OPINION ON DRUG SAFETY (2023)
Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors
Maria Konsta, Michael T. Nurmohamed, Alexios Iliopoulos, Petros P. Sfikakis, J. Christiaan van Denderen, Ingrid Visman, Grigorios T. Sakelariou, Irene E. van der Horst-Bruinsma
JOURNAL OF RHEUMATOLOGY (2023)
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study
Laure Gossec, Stefan Siebert, Paul Bergmans, Kurt de Vlam, Elisa Gremese, Beatriz Joven-Ibanez, Tatiana Korotaeva, Frederic Lavie, Wim Noel, Michael T. Nurmohamed, Petros P. Sfikakis, Mohamed Sharaf, Elke Theander, Josef S. Smolen
ANNALS OF THE RHEUMATIC DISEASES (2023)
Methotrexate Polyglutamates Exposure - Response Modeling in a Large Cohort of Rheumatoid Arthritis Patients Starting Methotrexate
Renske C. F. Hebing, Imke H. Bartelink, Helen R. Gosselt, Sandra G. Heil, Mauritis C. F. J. de Rotte, Pascal H. P. de Jong, Mike T. Nurmohamed, Robert de Jonge, Ron A. A. Mathot
CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)
Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases
Helen R. R. Gosselt, Jette A. A. van Lint, Leanne J. J. Kosse, Phyllis I. I. Spuls, Harald E. E. Vonkeman, Sander W. W. Tas, Frank Hoentjen, Michael T. T. Nurmohamed, Bart J. F. van den Bemt, Martijn B. A. van Doorn, Naomi T. T. Jessurun
EXPERT OPINION ON DRUG SAFETY (2023)
Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis
A. B. Blanken, M. Korteweg, L. van Boheemen, R. F. van Vollenhoven, M. T. Nurmohamed, C. J. van der Laken
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2023)
Do Disease-Modifying Anti-rheumatic Drugs and Exercise Therapy Have a Combined Effect on Disease Activity in Patients with RA? A Scoping Review
M. Sobejana, M. van der Esch, J. van den Hoek, G. Kitas, M. van der Leeden, M. T. Nurmohamed, G. S. Metsios
CURRENT RHEUMATOLOGY REPORTS (2023)
Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial
Mikkel Ostergaard, Ronald F. van Vollenhoven, Anna Rudin, Merete Lund Hetland, Marte Schrumpf Heiberg, Dan C. Nordstrom, Michael T. Nurmohamed, Bjorn Gudbjornsson, Lykke Midtboll Ornbjerg, Pernille Boyesen, Kristina Lend, Kim Horslev-Petersen, Till Uhlig, Tuulikki Sokka, Gerdur Grondal, Simon Krabbe, Joakim Lindqvist, Inger Gjertsson, Daniel Glinatsi, Meliha Crnkic Kapetanovic, Anna-Birgitte Aga, Francesca Faustini, Pinja Parmanne, Tove Lorenzen, Cagnotto Giovanni, Johan Back, Oliver Hendricks, Daisy Vedder, Tuomas Rannio, Emma Grenholm, Maud Kristine Ljosa, Eli Brodin, Hanne Lindegaard, Annika Soderbergh, Milad Rizk, Alf Kastbom, Per Larsson, Line Uhrenholt, Soren Andreas Just, David J. Stevens, Trine Bay Laurbjerg, Gunnstein Bakland, Inge Christoffer Olsen, Espen A. Haavardsholm, Jon Lampa, NORD-STAR Study Grp
ANNALS OF THE RHEUMATIC DISEASES (2023)
Patient perspective on exercise intervention in rheumatoid arthritis with high risk of cardiovascular disease: a pilot qualitative study
J. van den Hoek, M. Sobejana, F. van Nes, G. Metsios, G. Kitas, M. van der Leeden, M. T. Nurmohamed, M. van der Esch
RHEUMATOLOGY INTERNATIONAL (2023)
Predictors for response to electronic patient-reported outcomes in routine care in patients with rheumatoid arthritis: a retrospective cohort study
Jimmy Wiegel, Bart F. Seppen, Michael T. Nurmohamed, Marieke M. ter Wee, Wouter H. Bos
RHEUMATOLOGY INTERNATIONAL (2023)
Facilitators and barriers to adhere to monitoring disease activity with ePROs: a focus group study in patients with inflammatory arthritis
Bart F. F. Seppen, Jimmy Wiegel, Michael T. T. Nurmohamed, Wouter H. H. Bos, Marieke M. M. ter Wee
RHEUMATOLOGY INTERNATIONAL (2023)
Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated
Reinder Raadsen, Romy Hansildaar, Lianne C. Pouw, Femke Hooijberg, Laura Boekel, Gerrit Jan Wolbink, Arno W. R. van Kuijk, Michael T. Nurmohamed
RMD OPEN (2023)